Xi'an Guokang Ruijin Pharmaceutical

Xi'an Guokang Ruijin Pharmaceutical Co., Ltd. is a producer of glucocorticosteroid active pharmaceutical ingredients (APIs) with GMP certification in the Northwestern region of China. It is a subsidiary of Guokang Biomedical (Shenzhen) Co., Ltd. The company was founded in March 2018, with an initial capital of 50 million yuan. In June 2019, it acquired the pharmaceutical business operation rights of Xi'an Ruifeng Pharmaceutical Co., Ltd., transforming into a scientific and technological enterprise that integrates manufacturing, sales, and R&D. The company specializes in the manufacturing of steroid hormone APIs.